Impact Factor 3.831

Frontiers journals are at the top of citation and impact metrics

Correction ARTICLE

Front. Pharmacol., 30 August 2018 | https://doi.org/10.3389/fphar.2018.00949

Corrigendum: Oral Administration of α-Asarone Promotes Functional Recovery in Rats With Spinal Cord Injury

Min-Jae Jo1, Hemant Kumar1, Hari P. Joshi1, Hyemin Choi1, Wan-Kyu Ko1, J. M. Kim1, Sean S. S. Hwang1, Song Y. Park1, Seil Sohn1, Alvin B. Bello2, Kyoung-Tae Kim3, Soo-Hong Lee2, Xiang Zeng4* and Inbo Han1*
  • 1Department of Neurosurgery, CHA Bundang Medical Center, CHA University, Seongnam-si, South Korea
  • 2Department of Biomedical Science, CHA University, Seongnam-si, South Korea
  • 3Department of Neurosurgery, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, South Korea
  • 4Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China

A Corrigendum on
Oral Administration of α-Asarone Promotes Functional Recovery in Rats With Spinal Cord Injury

by Jo, M.-J., Kumar, H., Joshi, H. P., Choi, H., Ko, W.-K., Kim, J. M., et al. (2018) Front. Pharmacol. 9:445. doi: 10.3389/fphar.2018.00445

In the published article, there was an error in affiliation 3. The School of Medicine and Kyungpook National University were not mentioned. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: spinal cord injury, α-asarone, neuroprotection, anti-inflammation, M2 polarization

Citation: Jo M-J, Kumar H, Joshi HP, Choi H, Ko W-K, Kim JM, Hwang SSS, Park SY, Sohn S, Bello AB, Kim K-T, Lee S-H, Zeng X and Han I (2018) Corrigendum: Oral Administration of α-Asarone Promotes Functional Recovery in Rats With Spinal Cord Injury. Front. Pharmacol. 9:949. doi: 10.3389/fphar.2018.00949

Received: 31 July 2018; Accepted: 02 August 2018;
Published: 30 August 2018.

Approved by: Frontiers in Pharmacology Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2018 Jo, Kumar, Joshi, Choi, Ko, Kim, Hwang, Park, Sohn, Bello, Kim, Lee, Zeng and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xiang Zeng, zengx33@mail.sysu.edu.cn
Inbo Han, hanib@cha.ac.kr